本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunovant, Inc.

39.41
+0.04000.10%
盤後39.410.00000.00%19:34 EDT
成交量:72.71萬
成交額:2,862.00萬
市值:80.91億
市盈率:-14.22
高:39.87
開:39.80
低:38.70
收:39.37
52周最高:41.23
52周最低:14.32
股本:2.05億
流通股本:7,983.12萬
量比:0.82
換手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-2.7716
每股收益(LYR):-2.7716
淨資產收益率:-64.82%
總資產收益率:-38.43%
市淨率:9.49
市盈率(LYR):-14.22

資料載入中...

2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/06

重要事件披露

Form 8-K - Current report
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/11

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities